KYNA Ameliorates Hepatic Ischemia–Reperfusion Injury by Activating the Hippo Signalling Pathway via FTO ‐Dependent m6A Demethylation of LATS1
Cell Proliferation · 2025
DOI: 10.1111/cpr.70048 ↗At a glance
Journal article in Cell Proliferation, 2025. Written by Wenjie Zheng and 10 co-authors. Institution: Department of Hepatic Surgery, Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Major MEDLINE topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Reperfusion Injury, Protein Serine-Threonine Kinases, Liver. Cited 1 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (original language)
Hepatic ischemia–reperfusion injury (HIRI) substantially influences the prognosis of liver transplant recipients. Although kynurenic acid (KYNA) has been associated with protective effects against ischemia–reperfusion injury in various organs, the precise mechanisms underlying its protective role in HIRI are not well elucidated. In this study, a 70% mouse HIRI model and an in vitro hypoxia/reoxygenation model were employed to examine the protective effects of KYNA on HIRI. In this study, we illustrate that KYNA influences the methylation status of the Hippo signalling pathway by enhancing the expression of the fat mass and obesity‐associated gene (FTO). Within this pathway, large tumour suppressor kinase 1 (LATS1) is identified as a direct target of FTO. Moreover, the stability of LATS1 mRNA exhibits an inverse correlation with FTO levels and is modulated through its interaction with YTH N6‐Methyladenosine RNA Binding Protein F2 (YTHDF2). The reduction in LATS1 expression facilitated Yes‐associated protein (YAP) nuclear translocation, decreased hepatocyte apoptosis, and mitigated HIRI. Clinically, elevated levels of serum KYNA correlate with a diminished severity of liver injury post‐transplantation. our work revealed that KYNA possesses significant clinical translational potential for the prevention of HIRI, and further exploration of its underlying mechanisms was conducted.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Hepatic Surgery, Liver Transplantation, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- Department of Vascular Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Zhejiang, Hangzhou, China.
- Department of Thyroid and Breast Surgery, The Third Affiliated Lingnan Hospital of Sun Yat-Sen University, Guangzhou, China.
- Department of Pathology, Guangdong Provincial Hospital of Chiese Medicine, Guangzhou, China.
- Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
ORCID profiles: Wenjie Zheng
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Cite
APA
Zheng, W., Wang, X., Chen, H., He, K., Yan, X., Zhang, Y., Yang, Y., Zhang, P., Zhu, W., Zhu, S., & Li, H. (2025). KYNA Ameliorates Hepatic Ischemia–Reperfusion Injury by Activating the Hippo Signalling Pathway via FTO ‐Dependent m6A Demethylation of LATS1. Cell Proliferation. https://doi.org/10.1111/cpr.70048
Vancouver
Zheng W, Wang X, Chen H, He K, Yan X, Zhang Y, et al. KYNA Ameliorates Hepatic Ischemia–Reperfusion Injury by Activating the Hippo Signalling Pathway via FTO ‐Dependent m6A Demethylation of LATS1. Cell Proliferation. 2025. doi:10.1111/cpr.70048
BibTeX
@article{Zheng2025,
author = {Zheng, Wenjie and Wang, Xiaowen and Chen, Haoqi and He, Kaiming and Yan, Xijing and Zhang, Yuan and Yang, Yang and Zhang, Peng and Zhu, Wenfeng and Zhu, Shuguang and Li, Hua},
title = {KYNA Ameliorates Hepatic Ischemia–Reperfusion Injury by Activating the Hippo Signalling Pathway via FTO ‐Dependent m6A Demethylation of LATS1},
journal = {Cell Proliferation},
year = {2025},
doi = {10.1111/cpr.70048}
}
EUVIMED